DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Engelhardt M, Muller AM, Maier W. et al.
Severe irreversible bilateral hearing loss after bortezomib (VELCADE) therapy in a multiple myeloma (MM) patient. 
Leukemia 2005; 19: 869-870  

Download Bibliographical Data

Search in:
Access:
Access: